Related Experiment Video
Updated: May 16, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Clinical presentation and predictors of target vessel revascularization after drug-eluting stent implantation
Hazem Al Muradi1, Aditya Mehra, Joseph Okolo
1Division of Cardiology, Rhode Island Hospital, Brown University, 593 Eddy St, Providence, RI 02903, USA.
Insights
Clinically driven target vessel revascularization (TVR) after drug-eluting stent (DES) implantation is uncommon. Disease progression, not in-stent restenosis, is the primary driver for TVR, often presenting as acute coronary syndrome.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Biomedical Engineering
Background:
- Drug-eluting stent (DES) failure can lead to target vessel revascularization (TVR).
- Mechanisms of TVR in the DES era, including restenosis, stent thrombosis, and disease progression, require further elucidation.
- Understanding predictors and presentations of TVR post-DES is crucial for patient management.
Purpose of the Study:
- To examine the predictors and clinical presentations of patients undergoing clinically driven TVR after DES implantation.
- To differentiate the contributions of restenosis, stent thrombosis, and disease progression to TVR events.
Main Methods:
- Analysis of 2691 patients with 3401 lesions treated with DES from the Dynamic Registry (2004-2006).
- Comparison of patients with and without TVR at 2 years based on clinical, procedural, and angiographic data.
- Multivariate analysis to identify independent predictors of TVR and target lesion revascularization (TLR).
Main Results:
- TVR occurred in 7.2% of patients by 2 years; TLR in 3.8%.
- Disease progression accounted for 47% of TVR events; restenosis was the cause in 86.6% of TLR.
- Independent predictors of TVR included younger age, diabetes, graft lesion, long lesion length, and prior intervention.
Conclusions:
- The incidence of clinically driven TVR after DES is low.
- Disease progression is a major contributor to TVR, explaining acute coronary syndrome presentations.
- Low rates of in-stent restenosis and significant contribution of disease progression characterize TVR in the DES era.
Background:
Drug eluting stent (DES) failure including restenosis and stent thrombosis, or disease progression may result in target vessel revascularization (TVR) but the relative contribution of these mechanisms in the DES era is not well described. We sought to examine the predictors and presentations of patients with clinically driven TVR after DES.
Methods:
Patients with all lesions treated with a DES in the Dynamic Registry from 2004 to 2006 were analyzed. Included were 2691 patients with 3401 lesions. Patients with and without incident clinically driven TVR at 2years were compared according to baseline clinical, procedural, and angiographic characteristics and independent predictors of TVR and target lesion revascularization (TLR) were determined by multivariate analysis.
Results:
By 2-years, TVR occurred in 7.2% of patients and TLR in 3.8%, with 71.6% and 82.5% of repeat revascularization events occurring in the first year, respectively. The indication for first TVR was myocardial infarction in 18.6% (n=34), unstable angina in 42.6% (n=78), stable coronary disease in 25.7% (n=47) and other/unknown in 13.1% (n=24). Disease progression was responsible for 47% of TVR. Among patients with TLR, restenosis was the mechanism in 86.6% and stent thrombosis in 13.4%. Independent predictors of TVR included younger age, diabetes, attempted graft lesion, lesion length >30mm and prior lesion intervention. Independent predictors of TVR and TLR were similar.
Conclusion:
The incidence of clinically driven TVR is low in patients treated with DES and nearly half is attributable to disease progression, which along with the low rate of in-stent restenosis explains why the mode of presentation is often an acute coronary syndrome.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Atherosclerosis III: Management
Acute Coronary Syndrome III: Diagnostic Studies